Decreased specific antibody response to polysaccharide vaccine
Basic details
Preferred term: Decreased specific antibody response to polysaccharide vaccine
Alt. terms:
HPO term: Decreased specific antibody response to polysaccharide vaccine
HPO code: HP:0410299
GenIA ID: 15802
Last updated on: 2021-08-02 21:50:33
Cross ref. with other ontologies
NCIT: -
MESH: -
EFO: -
OAE: -
SNOMEDCT: -
ICD10: -
Description
A reduced ability to synthesize postvaccination antibodies against polysaccharides in vaccines, as measured by antibody titer determination following vaccination.
Hierarchical classification
PARENT terms
TERM
Decreased specific antibody response to polysaccharide vaccine
Reported patients added to GenIA DB
SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
---|---|---|---|---|---|---|---|
101015 | M | 210203 | - | German | Absent ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [Fam.MM:II.1]; PMID:29729943 [Fam.MM:II.1(87)]; PMID:34975878 [Fam.F002:P002]; PMID:31857261 [Patient 3] |
101019 | F | 210316 | - | German | Absent ab-response to pneumococcal polysaccharide vaccine | PMID:34975878 [Fam.F004:P004] | |
101023 | M | 210731 | 34 | German | Negative ab-response to vaccination | PMID:34975878 [Fam.F008:P008] | |
101045 | M | 210205![]() |
- | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:III.13(A.III.3)]; PMID:29729943 [Fam.A:III.3(9)]; PMID:34975878 [Fam.F018:III.2(P018)]; PMID:27418640 [P11(5)] |
101051 | F | 210205![]() |
- | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:III.5(A.III.1)]; PMID:30250467 [A.III.1]; PMID:29729943 [Fam.A:III.5(A.III.1 (8))]; PMID:34975878 [Fam.F018:III.1(P021)]; PMID:27418640 [P10(5)] |
101078 | F | 211301 | 51 | Absent ab-response to pneumococcal polysaccharide vaccine | PMID:34975878 [Fam.F044:P044] | ||
101086 | M | 210934 | - | German | Absent ab-response to pneumococcal polysaccharide vaccine | PMID:34975878 [Fam.F052:P052] | |
101128 | M | 210897 | - | Caucasian | Absent ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.OO:II.1(95)]; PMID:37740092 [P07] |
101129 | F | 210906 | - | German | Absent ab-response to pneumococcal polysaccharide vaccine | PMID:34975878 [Fam.F078:P078] | |
101132 | M | 210304 | 30 | German | Absent ab-response to pneumococcal polysaccharide vaccine | PMID:34975878 [Fam.F081:P081] | |
101134 | F | 210901 | - | Absent ab-response to pneumococcal polysaccharide vaccine | PMID:34975878 [Fam.F083:P083] | ||
101143 | F | 211219 | - | Absent ab-response to pneumococcal polysaccharide vaccine | PMID:34975878 [Fam.F088:P088] | ||
101171 | M | 210012![]() |
7 | Dutch | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 20 | PMID:25926555 [Patient(II.1)] |
101199 | F | 211483 | - | German | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.YY:II.1(127)]; PMID:34975878 [Fam.F122:P122] |
101403 | M | 210189![]() |
- | German | Absent ab-response to pneumococcal polysaccharide vaccine | Adenosine deaminase 2 deficiency | PMID:28493328 [P3]; PMID:26922074 [Index(II.2)] |
101425 | M | 210205![]() |
- | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:II.8(A.II.5)]; PMID:29729943 [Fam.A:II.8(A.II.5 (4))]; PMID:27418640 [P7(5)] |
101458 | F | 210656![]() |
- | Georgian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.E:II.3(E.II.3)]; PMID:29729943 [Fam.E:II.3(E.II.3 (23))]; PMID:27418640 [P19(5)] |
101461 | M | 210929 | - | German | Absent ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:34975878 [Fam.F153:P153]; PMID:32278790 [Z.I.1]; PMID:29403474 [Patient 27 (11)]; PMID:27923702 [Patient 6]; PMID:150198 [Fam.AL:151]; PMID:27461466 [Fam.830_01:27] |
101504 | F | 211125 | 7 | Absent ab-response to pneumococcal polysaccharide vaccine | PMID:34975878 [Fam.F169:P169] | ||
101543 | F | 210011 | 23 | Absent ab-response to pneumococcal polysaccharide vaccine | PMID:34975878 [Fam.F179:P179] | ||
101553 | M | 210256 | - | German | Absent ab-response to pneumococcal polysaccharide vaccine | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F182:P182] |
101617 | M | 210994 | - | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 2 | PMID:34975878 [Fam.F212:P212] | |
101723 | F | 210261![]() |
- | Asian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.D:I.2(D.I.2)]; PMID:29729943 [Fam.D:I.2(D.I.2 (21))] |
101727 | M | 210300![]() |
45 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:II.1(P1)] |
101732 | M | 210300![]() |
15 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:III.4(P3)] |
101733 | M | 210300![]() |
16 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:III.6(P4)] |
101735 | F | 210300![]() |
13 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:III.8(P5)] |
101736 | M | 210300![]() |
11 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:III.9(P6)] |
101737 | M | 210300![]() |
16 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:III.10(P7)] |
101738 | M | 210300![]() |
13 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:III.11(P8)] |
101740 | M | 210300![]() |
9 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:III.13(P9)] |
101741 | F | 210300![]() |
7 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:III.14(P10)] |
101757 | M | 210026 | 11 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 8 | PMID:26768763 [Fam.605:P14]; PMID:26206937 [P3] |
101758 | M | 210027 | 10 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 8 | PMID:26768763 [Fam.606:P15]; PMID:26206937 [P5] |
101759 | F | 210028 | 12 | North American | Absent ab-response to pneumococcal polysaccharide vaccine | Immunodeficiency, common variable, 8 | PMID:26768763 [Fam.607:P16]; PMID:26206937 [P4] |
101800 | M | 215769![]() |
- | Caucasian | Absent ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:34975878 [Fam.F259:P259]; PMID:32278790 [Fam.AT:III.2(III.2)]; PMID:150198 [Fam.BT:IV.1(319)]; PMID:31803180 [Fam.C:III.1(III.1)] |
102224 | F | 214919 | - | German | Absent ab-response to pneumococcal polysaccharide vaccine | DiGeorge syndrome | PMID:35486341 [P017] |
102731 | F | 214982![]() |
8 | Colombian | Negative ab-response to vaccination | Immunodeficiency 99 | PMID:32484799 [Patient(II.2)] |
103999 | M | 215320![]() |
- | Reduced ab-response to pneumococcal polysaccharide vaccine | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25359994 [P3] | |
104000 | M | 215321 | - | Reduced ab-response to pneumococcal polysaccharide vaccine | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25359994 [P4] | |
104985 | F | 215622![]() |
- | Dutch | Negative ab-response to vaccination | PMID:32278790 [Fam.NA:IV.3(IV.3)]; PMID:26279205 [Fam.NL1:IV.4(46)]; PMID:11583829 [Fam.1:IV.3(IV:2)]; PMID:16639407 [Fam.1:IV.4(46)]; PMID:150198 [Fam.AA:IV.4(060)] | |
104989 | F | 215622![]() |
- | Dutch | Negative ab-response to vaccination | NFKB1 insufficiency | PMID:32278790 [Fam.NA:IV.7(IV.7)]; PMID:26279205 [Fam.NL1:IV.8(49)]; PMID:29403474 [Fam.NL1 (5):IV.8(49)]; PMID:11583829 [Fam.1:IV.6(IV:6)]; PMID:16639407 [Fam.1:IV.6(49)]; PMID:150198 [Fam.AA:IV.8(064)] |
105075 | M | 215636 | - | Spanish | Reduced ab-response to pneumococcal polysaccharide vaccine | Combined immunodeficiency 36 | PMID:35464398 [P5(II.1)] |
105175 | M | 215660 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.Q:II.1(Q.II.1 (44))]; PMID:27102614 [Fam.B:I.1(2)] |
105176 | F | 215661 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.L:II.1(L.II.1 (35))]; PMID:27102614 [Fam.C:II.1(3)] |
105179 | F | 215661 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.L:I.2(L.I.2 (34))]; PMID:27102614 [Fam.C:I.2(mother)] |
105180 | M | 215662 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.S:II.1(S.II.1 (47))]; PMID:27102614 [Fam.D:II.1(5)] |
105197 | M | 215666![]() |
31 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:32278790 [Fam.F1:III.3(III.3)]; PMID:29403474 [Fam.1 (9):III.3(F1.III-3)]; PMID:28115215 [Fam.1:III.3(F1.III-3)]; PMID:150198 [Fam.AQ:III.3(177)]; PMID:36356849 [Fam.6:III.3(F6:III:3)]; PMID:36105815 [Fam.H67R:III.3(H67R/4)] |
105212 | F | 215666![]() |
50 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:32278790 [Fam.F1:II.4(II.4)]; PMID:29403474 [Fam.1 (9):II.4(F1.II-4)]; PMID:28115215 [Fam.1:II.4(F1.II-4)]; PMID:150198 [Fam.AQ:II.4(174)]; PMID:36356849 [Fam.6:II.4(F6:II:4)]; PMID:36105815 [Fam.H67R:II.4(H67R/2)] |
105214 | F | 215666![]() |
40 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:32278790 [Fam.F1:III.2(III.2)]; PMID:29403474 [Fam.1 (9):III.2(F1.III-2)]; PMID:28115215 [Fam.1:III.2(F1.III-2)]; PMID:150198 [Fam.AQ:III.2(176)]; PMID:36356849 [Fam.6:III.2(F6:III:2)]; PMID:36105815 [Fam.H67R:III.2(H67R/3)] |
105218 | F | 215666![]() |
25 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:32278790 [Fam.F1:III.6(III.6)]; PMID:29403474 [Fam.1 (9):III.6(F1.III-6)]; PMID:28115215 [Fam.1:III.6(F1.III-6)]; PMID:150198 [Fam.AQ:III.6(180)]; PMID:36356849 [Fam.6:III.6(F6:III:6)]; PMID:36105815 [Fam.H67R:III.6(H67R/5)] |
105220 | F | 215666![]() |
15 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:32278790 [Fam.F1:III.8(III.8)]; PMID:29403474 [Fam.1 (9):III.8(F1.III-8)]; PMID:28115215 [Fam.1:III.8(F1.III-8)]; PMID:150198 [Fam.AQ:III.8(182)]; PMID:36356849 [Fam.6:III.8(F6:III:8)]; PMID:36105815 [Fam.H67R:III.8(H67R/7)] |
105221 | M | 215666![]() |
10 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:32278790 [Fam.F1:IV.2(IV.2)]; PMID:28115215 [Fam.1:IV.1(F1.IV-1)]; PMID:150198 [Fam.AQ:IV.1(183)]; PMID:36356849 [Fam.6:IV.1(F6:IV:1)]; PMID:36105815 [Fam.H67R:IV.1(H67R/8)] |
105225 | F | 215671![]() |
57 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:32278790 [Fam.F2:II.2(II.2)]; PMID:29403474 [Fam.2 (9):II.3(F2.II-3)]; PMID:28115215 [Fam.2:II.3(F2.II-3)]; PMID:150198 [Fam.AR:II.3(191)]; PMID:36356849 [Fam.5:II.2(F5:II:2)] |
105231 | M | 215671![]() |
26 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:32278790 [Fam.F2:III.2(III.2)]; PMID:29403474 [Fam.2 (9):III.2(F2.III-2)]; PMID:28115215 [Fam.2:III.2(F2.III-2)]; PMID:150198 [Fam.AR:III.2(193)]; PMID:36356849 [Fam.5:III.2(F5:III:2)] |
105363 | F | 215722 | - | Afro-American | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.X:II.1(X.II.1 (59))]; PMID:28366794 [Fam.A:II.1(P1)] |
105365 | F | 215722 | - | Afro-American | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.X:I.2(X.I.2 (58))]; PMID:28366794 [Fam.A:I.2(mother)] |
105475 | F | 215776![]() |
- | European | Negative ab-response to vaccination | Ezrin immunodeficiency | PMID:37301410 [P1(II.4)] |
105488 | M | 215781 | - | Absent ab-response to pneumococcal polysaccharide vaccine | Hyper-IgE recurrent infection syndrome 1 | PMID:28983403 [P2] | |
105587 | F | 215820 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | Activated p110-delta syndrome 1 | PMID:24610295 [Fam.1:II.1(F1P1)] |
105609 | M | 215821 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | Activated p110-delta syndrome 1 | PMID:24610295 [Fam.2:III.1(F2P3)] |
105616 | F | 215822 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | Activated p110-delta syndrome 1 | PMID:25352054 [Fam.1:II.4(P1)] |
105623 | M | 215822 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | Activated p110-delta syndrome 1 | PMID:25352054 [Fam.1:II.6(P2)] |
105626 | M | 215822 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | Activated p110-delta syndrome 1 | PMID:25352054 [Fam.1:III.1(P3)] |
105627 | F | 215822 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | Activated p110-delta syndrome 1 | PMID:25352054 [Fam.1:III.2(P4)] |
105628 | F | 215822 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | Activated p110-delta syndrome 1 | PMID:25352054 [Fam.1:III.3(P5)] |
105791 | F | 215877![]() |
- | Spanish | Negative ab-response to vaccination | Immunodeficiency, common variable, 14 | PMID:37876937 [Fam.1:II.1(1.1)] |
105794 | M | 215878![]() |
- | Spanish | Negative ab-response to vaccination | Immunodeficiency, common variable, 14 | PMID:37876937 [Fam.2:II.1(2.1)] |
105844 | M | 215889![]() |
- | Spanish | Negative ab-response to vaccination | Immunodeficiency, common variable, 14 | PMID:37876937 [Fam.4:II.1(4.1)] |
105847 | M | 215890![]() |
- | Spanish | Negative ab-response to vaccination | Immunodeficiency, common variable, 14 | PMID:37876937 [Fam.5:II.1(5.1)] |
105981 | M | 215919 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.Y:II.1(Y.II.1 (61))] |
105986 | F | 215921![]() |
- | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.FG:II.2(630)]; PMID:36203612 [Fam.1:II.2(1.II.1)] | |
105990 | F | 215921![]() |
- | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.FG:III.1(631)]; PMID:36203612 [Fam.1:III.1(1.III.1)] | |
105991 | M | 215922![]() |
- | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.FH:II.1(634)]; PMID:36203612 [Fam.2:II.2(2.II.1)] | |
105999 | F | 215922![]() |
- | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.FH:III.1(640)]; PMID:36203612 [Fam.2:III.1(2.III.1)] | |
106044 | F | 215929 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.KK:II.1(KK.II.1 (85))] |
106068 | M | 215931 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.PP:II.1(PP.II.1 (96))] |
106069 | F | 215932 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.RR:II.1(RR.II.1 (98))] |
106077 | M | 215934 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.TT:II.4(TT.II.4 (103))] |
106078 | M | 215934 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.TT:II.5(TT.II.5 (104))] |
106097 | M | 215948 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.WW:II.1(WW.II.1 (125))] |
106099 | M | 210955 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.ZZ:II.1(ZZ.II.1 (129))] |
106200 | F | 215975![]() |
69 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.FM:III.2(693)]; PMID:36356849 [Fam.2:III.2(F2:III:2)] |
106209 | F | 215975![]() |
71 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.FM:III.3(694)]; PMID:36356849 [Fam.2:III.3(F2:III:3)] |
106216 | F | 215975![]() |
41 | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.FM:IV.2(701)]; PMID:36356849 [Fam.2:IV.2(F2:IV:2)] |
106223 | M | 215976![]() |
- | Finnish | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.FN:II.1(710)]; PMID:36356849 [Fam.4:II.1(F4:II:1)]; PMID:38593810 [Fam.3:II.1(F3.II-1)] |
106248 | F | 215977 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.UU:III.15(UU.III.10 (113))]; PMID:29305966 [Fam.IV.2:III.4(III.5)] |
106279 | M | 215977 | - | Caucasian | Reduced ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.UU:V.2(UU.V.2 (122))]; PMID:29305966 [Fam.IV.2:V.1(V.1)] |
106371 | M | 216004 | 22 | Absent ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29375547 [Fam.A:II.1(A.II.1)]; PMID:31396201 [P2(II.1)] | |
106390 | M | 216005 | - | Absent ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:32996901 [Patient(II.1)] | |
106393 | F | 216006![]() |
20 | German | Absent ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:36273440 [III.3(III.3)] |
106463 | F | 216023![]() |
- | Japanese | Negative ab-response to vaccination | NFKB1 insufficiency | PMID:150198 [Fam.FX:II.3(779)]; PMID:38514645 [Fam.1:II.3(proband)] |
106646 | M | 216099 | - | Absent ab-response to pneumococcal polysaccharide vaccine | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:34628649 [Patient(III.1)] | |
106676 | F | 216106![]() |
68 | Dutch | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.ET:I.2(598)]; PMID:36105815 [Fam.G64V:I.2(G64V/1)] |
106954 | M | 216196![]() |
- | Reduced ab-response to pneumococcal polysaccharide vaccine | NFKB1 insufficiency | PMID:150198 [Fam.GB:II.2(797)]; PMID:38901617 [Fam.2:II.2(P2)] | |
107043 | M | 216282 | - | Reduced ab-response to pneumococcal polysaccharide vaccine | Activated p110-delta syndrome 1 | PMID:27444043 [P1] | |
107044 | M | 216283 | - | Reduced ab-response to pneumococcal polysaccharide vaccine | Activated p110-delta syndrome 1 | PMID:28983403 [P1] | |
107156 | F | 216365![]() |
10 | Turkish | Reduced ab-response to pneumococcal polysaccharide vaccine | Hyper-IgE recurrent infection syndrome 2 | PMID:39437980 [Fam.B:II.2(Patient 2)] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).